Condition: Overweight and Obesity · Inflammation · Metabolic Syndrome · Sponsor: University of Rijeka
This observational study aims to evaluate the diagnostic and prognostic value of the systemic immune-inflammatory index (SII) and the systemic inflammation response index (SIRI) in individuals with overweight or obesity. The study will assess their association with obesity status, metabolic complications, lifestyle patterns, dietary indices, and established inflammatory biomarkers. Participants will undergo anthropometric assessment, laboratory testing, dietary evaluation, and follow-up for response to different obesity treatment modalities over 3 years. The study intends to determine whether SII and SIRI can serve as clinically useful predictors of metabolic risk and treatment outcomes of obesity.
This description comes directly from the study's public registry record.
Gordana Kenđel Jovanović, Asst.Prof. · +385912030704 · gordanakj@uniri.hr
Jelena Vresk Špiranec, MD, spec. endocrinology · +385995112141 · jelenavresk@gmail.com
Always discuss trial participation with your own doctor first.
| General Hospital Varaždin | Varaždin, Croatia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07431593